186 related articles for article (PubMed ID: 24212659)
21. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.
Gower WR; Vesely BA; Alli AA; Vesely DL
Int J Gastrointest Cancer; 2005; 36(2):77-87. PubMed ID: 16648657
[TBL] [Abstract][Full Text] [Related]
22. Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.
Lane ML; Frost CD; Nguyen JP; Skelton WP; Skelton M; Vesely DL
Mol Cell Biochem; 2012 Dec; 371(1-2):209-15. PubMed ID: 22965761
[TBL] [Abstract][Full Text] [Related]
23. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jan; 35(1):60-9. PubMed ID: 15638821
[TBL] [Abstract][Full Text] [Related]
24. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(6B):3813-8. PubMed ID: 18225537
[TBL] [Abstract][Full Text] [Related]
26. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.
Manimala NJ; Frost CD; Lane ML; Higuera M; Beg R; Vesely DL
Eur J Clin Invest; 2013 Nov; 43(11):1156-62. PubMed ID: 23992401
[TBL] [Abstract][Full Text] [Related]
27. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Eur J Clin Invest; 2006 Nov; 36(11):810-9. PubMed ID: 17032349
[TBL] [Abstract][Full Text] [Related]
28. Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells.
Vesely BA; Alli AA; Song SJ; Gower WR; Sanchez-Ramos J; Vesely DL
Eur J Clin Invest; 2005 Nov; 35(11):700-10. PubMed ID: 16269020
[TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Lenz A; Skelton WP; Wang H; Vesely DL
Anticancer Res; 2009 Jun; 29(6):1889-93. PubMed ID: 19528444
[TBL] [Abstract][Full Text] [Related]
30. Four peptides decrease the number of human pancreatic adenocarcinoma cells.
Vesely BA; McAfee Q; Gower WR; Vesely DL
Eur J Clin Invest; 2003 Nov; 33(11):998-1005. PubMed ID: 14636304
[TBL] [Abstract][Full Text] [Related]
31. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.
Vesely BA; Fitz SR; Gower WR; Vesely DL
Cancer Lett; 2006 Feb; 233(2):226-31. PubMed ID: 15893414
[TBL] [Abstract][Full Text] [Related]
32. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2006; 26(6B):4143-8. PubMed ID: 17201125
[TBL] [Abstract][Full Text] [Related]
33. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
34. Central role of β-catenin in anticancer effects of cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
[TBL] [Abstract][Full Text] [Related]
35. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
[TBL] [Abstract][Full Text] [Related]
36. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
[TBL] [Abstract][Full Text] [Related]
37. Four cardiac hormones cause cell death of melanoma cells and inhibit their DNA synthesis.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Am J Med Sci; 2007 Nov; 334(5):342-9. PubMed ID: 18004088
[TBL] [Abstract][Full Text] [Related]
38. Primary malignant tumors of the heart: four cardiovascular hormones decrease the number and DNA synthesis of human angiosarcoma cells.
Vesely BA; Alli A; Song S; Sanchez-Ramos J; Fitz SR; Gower WR; Vesely DL
Cardiology; 2006; 105(4):226-33. PubMed ID: 16534199
[TBL] [Abstract][Full Text] [Related]
39. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Vesely DL; Perez-Lamboy GI; Schocken DD
Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
[TBL] [Abstract][Full Text] [Related]
40. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
Chiou S; Vesely DL
Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
